Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Asset Utilization Ratio data on record, last reported at 0.75 in Q2 2025.

  • For Q2 2025, Asset Utilization Ratio changed N/A year-over-year to 0.75; the TTM value through Jun 2025 reached 0.75, changed N/A, while the annual FY2024 figure was 0.48, 553.61% up from the prior year.
  • Asset Utilization Ratio reached 0.75 in Q2 2025 per ARQT's latest filing, up from 0.6 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.75 in Q2 2025 and bottomed at 0.01 in Q4 2022.
  • Average Asset Utilization Ratio over 4 years is 0.26, with a median of 0.15 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: surged 1993.19% in 2023, then surged 163.06% in 2024.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then soared by 1993.19% to 0.16 in 2023, then soared by 163.06% to 0.42 in 2024, then soared by 75.86% to 0.75 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.75 in Q2 2025, 0.6 in Q1 2025, and 0.42 in Q4 2024.